| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/29/2009 | EP1624896B1 Method for the production of a stable injectable formulation made of paclitaxel |
| 07/29/2009 | EP1572219A4 Efficient method for producing compositions enriched in total phenols |
| 07/29/2009 | EP1572197B1 4- 1- (sulfonyl) -1h-indol-2-yl)-4- (hydroxy) -cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents |
| 07/29/2009 | EP1517911B1 Tumour-inhibiting platinum (ii) oxalate complexes |
| 07/29/2009 | EP1517716B1 Polyacrylates coatings for implantable medical devices |
| 07/29/2009 | EP1513527B1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers |
| 07/29/2009 | EP1495014B1 Flavanoids derivatives as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| 07/29/2009 | EP1461025A4 Treatment of neurodegenerative and cardiovascular disorders |
| 07/29/2009 | EP1455772B1 Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation |
| 07/29/2009 | EP1432441B1 Use of hmgb1 for the activation of dendritic cells |
| 07/29/2009 | EP1411895B2 Oral pharmaceutical composition comprising an active principle capable of being subjected to high effect during its first passage through the intestine |
| 07/29/2009 | EP1409468B9 Guanidinobenzamides as mc4-r agonists |
| 07/29/2009 | EP1406608B1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 07/29/2009 | EP1401473B1 Transporters comprising spaced arginine moieties |
| 07/29/2009 | EP1399221B1 Compositions comprising oestrone-3-o-sulphamate and trail (tnf-related apoptosis inducing ligand) |
| 07/29/2009 | EP1397357B1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 07/29/2009 | EP1395587B1 Process for the preparation of imipenem |
| 07/29/2009 | EP1363876B1 Glucocorticoid receptor modulators |
| 07/29/2009 | EP1347805B1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/29/2009 | EP1326596B1 Pharmaceutical preparations containing a dibenzocyclooctane lignan derivative for prevention and treatment of neurodegenerative disease |
| 07/29/2009 | EP1293567B1 Ligand to gpr8 and dna thereof |
| 07/29/2009 | EP1292676B1 Mutation associated with epilepsy |
| 07/29/2009 | EP1287125B1 Dna sequences encoding dystrophin minigenes and methods of use thereof |
| 07/29/2009 | EP1278494B1 Device and method for treating urinary incontinence in females |
| 07/29/2009 | EP1268443B1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 07/29/2009 | EP1261601B1 Substituted indoles for modulating nfkb activity |
| 07/29/2009 | EP1260215B1 Rapidly disintegrable tablet containing polyvinyl alcohol |
| 07/29/2009 | EP1189641B1 HUMANIZED ANTI-ErbB2 ANTIBODIES AND TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 07/29/2009 | EP1075191B2 Phytosterol compositions |
| 07/29/2009 | EP0879284B1 Gene expression vectors which generate an antigen specific immune response and methods of using the same |
| 07/29/2009 | EP0854726B2 Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions |
| 07/29/2009 | CN101495512A A diabody which specifically binds streptococcus surface antigen I/II and methods of use thereof |
| 07/29/2009 | CN101495124A Fucoidan compositions and methods |
| 07/29/2009 | CN101495123A Methods and compositions for increasing the safety and efficacy of albumin-binding drugs |
| 07/29/2009 | CN101495122A Treprostinil administration using a metered dose inhaler |
| 07/29/2009 | CN101495121A Methods for the treatment of substance abuse and dependence |
| 07/29/2009 | CN101495120A Composition for induction or inhibition of stem cell differentiation |
| 07/29/2009 | CN101495119A Soluble epoxide hydrolase inhibitors |
| 07/29/2009 | CN101495118A N-(arylamino)-sulfonamide inhibitors of mek |
| 07/29/2009 | CN101495117A Aqueous liquid preparation containing amide compound |
| 07/29/2009 | CN101495116A Treatment of protein degradation disorders |
| 07/29/2009 | CN101495115A Combination therapy |
| 07/29/2009 | CN101495114A Treatment and prevention mucositis by anthocyanidin derivatives |
| 07/29/2009 | CN101495113A IL-8 receptor antagonists |
| 07/29/2009 | CN101495112A Dietary or pharmaceutical compositions containing tricyclic diterpenes and derivatives thereof for the treatment of depression. |
| 07/29/2009 | CN101495111A Methods and compositions using immunomodulatory compounds in combination therapy |
| 07/29/2009 | CN101495110A Compositions and methods useful for treatment of respiratory illness |
| 07/29/2009 | CN101495109A Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin reuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor |
| 07/29/2009 | CN101495108A Composition for the treatment of resistant cancers comprising oridonin |
| 07/29/2009 | CN101495107A Method of removing parasites on body surface of fishes |
| 07/29/2009 | CN101495106A Treatment with azetidinone-based cholesterol absorption inhibitors and omega-3 fatty acids and a combination product thereof |
| 07/29/2009 | CN101492416A Compounds effecting glucokinase |
| 07/29/2009 | CN101491670A Method for treating cardiovascular disease using nervous regulation protein and composite |
| 07/29/2009 | CN101491537A Glacial acetic acid chitosan composite antibiotic liquid |
| 07/29/2009 | CN101491536A Therapeutically useful synthetic oligonucleotides |
| 07/29/2009 | CN101491535A Method for preparing azithromycin composition with reduced bitter |
| 07/29/2009 | CN101491534A Use of paeoniflorin in preparing medicine for treating menopause syndrome |
| 07/29/2009 | CN101491533A Use of baicalin in preparing medicine |
| 07/29/2009 | CN101491532A Erigeron breviscapus eye-preparation and preparation method thereof |
| 07/29/2009 | CN101491531A Use of bufadienolides compound and bufadienolides salinization compound in preparing medicine for treating gynecological tumor |
| 07/29/2009 | CN101491530A Use of sterols compound and total-sterol extract in preparing analgesic |
| 07/29/2009 | CN101491529A Piroxicam belta-cyclodextrin inclusion compound micro-pill capsules |
| 07/29/2009 | CN101491528A Anti-hepatitis b virus medicine dispersion combination at non-crystal state and medicine preparation thereof |
| 07/29/2009 | CN101491527A Use of tetrahydropyridines in preparing medicine for treating hepatitis or hepatocirrhosis |
| 07/29/2009 | CN101491526A Use of tetrahydropyridines in preparing medicine for treating arthritis |
| 07/29/2009 | CN101491525A Use of tetrahydropyridines in preparing medicine for treating oerophthalma |
| 07/29/2009 | CN101491524A Medicine combination capable of improving cetirizine preparation stability |
| 07/29/2009 | CN101491523A Combination containing micronized gliquidone |
| 07/29/2009 | CN101491522A Composite artesunate capsules |
| 07/29/2009 | CN101491521A Medicine combination with diarrhea relieving function |
| 07/29/2009 | CN101491520A Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 07/29/2009 | CN101491519A Bilobalide injector and preparation method thereof |
| 07/29/2009 | CN101491518A Combination for treating tumor |
| 07/29/2009 | CN101491517A Use of T-2 toxin in preparing anti-tumor medicine |
| 07/29/2009 | CN101491516A Use of tanshinone compound and total-tanshinone extract in preparing analgesic |
| 07/29/2009 | CN101491515A Use of paclitaxel in preparing medicine for preventing and treating idiopathic pulmonary fibrosis |
| 07/29/2009 | CN101491514A Use of phenylalanine derivative in preparing anti-hepatic-B virus medicine |
| 07/29/2009 | CN101491513A New use of Radix Salviae Miltiorrhizae in treating wean pneumonia |
| 07/29/2009 | CN101491512A Bismuth salt composite for treating stomach intestine disease and preparation method thereof |
| 07/29/2009 | CN101491511A Use of Hirsutanols A in preparing anti-tumor medicine |
| 07/29/2009 | CN101491510A New use of propofol |
| 07/29/2009 | CN100519757C Tiacumicin production |
| 07/29/2009 | CN100519561C Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol |
| 07/29/2009 | CN100519558C Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and the use thereof in the production of a medicament |
| 07/29/2009 | CN100519555C Novel indole derivative for alkylating specific base sequence of DNA, alkylating agent using the same and medicament |
| 07/29/2009 | CN100519554C CCR5 antagonists for treating aids |
| 07/29/2009 | CN100519553C Inhiitors of cyclin dependent kinases as anti-cancer agent |
| 07/29/2009 | CN100519552C Pyrazole compounds |
| 07/29/2009 | CN100519550C 2-oxo-indole compound having a functtion of inhibiting glycogen synthase kinase-3 |
| 07/29/2009 | CN100519549C Pyrimidine derivatives and pharmaceutical compositions containing the compounds |
| 07/29/2009 | CN100519539C N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/29/2009 | CN100519528C Compounds with analgesic effect |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100519526C Azabicyclo derivatives as muscarinic receptor antagonists |
| 07/29/2009 | CN100519525C Aromatic sulfones and their medical use |
| 07/29/2009 | CN100518831C Solid nano-medicine and preparing method thereof |
| 07/29/2009 | CN100518827C Controlled release hydrocodone formulations |
| 07/29/2009 | CN100518820C A Pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor |
| 07/29/2009 | CN100518816C Application of neurotoxin therapy for the treatment of urinary system disease or related diseases |
| 07/29/2009 | CN100518748C Emulsion containing plant extract, method for producing said emulsion and for obtaining plant extract |